Alembic Pharma plans Rs 720-crore capex for FY19 Ruby Khatun Khatun4 Jun 2018 10:00 AM ISTAlembic Pharmaceuticals has earmarked a capital expenditure of Rs 720 crore for this fiscal year to complete existing projects and on maintenance, a...
Roche's Perjeta wins approval in Europe for expanded use Ruby Khatun Khatun4 Jun 2018 9:45 AM ISTZURICH: Roche won European Union approval for its Perjeta medicine to treat a type of breast cancer whose sufferers are at a high risk of...
Merck's Keytruda extends lung cancer survival in two trials Ruby Khatun Khatun4 Jun 2018 9:30 AM ISTCHICAGO: Merck & Co’s immunotherapy Keytruda improved survival as a stand-alone treatment for newly-diagnosed lung cancer patients and with...
Drug Technical Advisory Board Calls for Hearing on banned 344 FDC drugs, check out details Ruby Khatun Khatun3 Jun 2018 11:30 AM ISTNew Delhi: Through a recent public notification, Directorate General of Health Services Office of Drugs Controller General (India) (FDC Division) has...
Gap in regulating biotech drug copies prompts WHO to step in Ruby Khatun Khatun3 Jun 2018 10:30 AM ISTLONDON: Cut-price copies of expensive biotech drugs promise to slash the cost of treating serious diseases, including cancer, in rich and poor...
Lupin appoints Nicholas Hart as head of specialty business in US Ruby Khatun Khatun3 Jun 2018 10:15 AM ISTNew Delhi: Drug maker Lupin said it has appointed Nicholas Hart as President of its Specialty business in the US.Hart will lead the specialty...
Allergan to sell women's health, infectious disease units Ruby Khatun Khatun3 Jun 2018 9:45 AM ISTNEW YORK: Drugmaker Allergan Plc said it plans to sell two of its smaller businesses, the women’s health, and infectious disease units, as Chief...
AstraZeneca drug Fasenra fails to achieve main goal in COPD trial Ruby Khatun Khatun3 Jun 2018 9:30 AM ISTAstraZeneca’s first respiratory biological medicine Fasenra failed to meet its main target in a second clinical trial treating patients with moderate...
Lupin launches oral antibiotic Solosec in US Ruby Khatun Khatun2 Jun 2018 10:30 AM ISTNew Delhi: Drug major Lupin said it has launched Solosec, an oral antibiotic used in treating bacterial vaginosis (BV) in women, in the US market.The...
Granules India's US arm launches generic Methergine tablets in US market Ruby Khatun Khatun2 Jun 2018 10:15 AM ISTNew Delhi: Granules India Ltd said its US subsidiary has launched the generic version of Methergine (Methylergonovine Maleate) tablets, in partnership...
AstraZeneca expands its GMD Centre in India Ruby Khatun Khatun2 Jun 2018 10:00 AM ISTGlobal science-led biopharmaceutical company AstraZeneca officially opened its new Global Medicines Development (GMD) Centre in Bengaluru, India.This...
Pfizer receives FDA breakthrough therapy designation for XALKORI Ruby Khatun Khatun2 Jun 2018 9:45 AM ISTNEW YORK: Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for XALKORI® (crizotinib)...
